Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Conference Coverage

Conference Coverage
Real-World Treatment Patterns in US Veterans With Nonmetastatic Castration–Resistant Prostate Cancer
06/03/2022

Marta Rybczynski

Marta Rybczynski
Despite the recent approval of several nmCRPC treatments that have demonstrated improved metastasis-free survival and quality of life, first-generation antiandrogens remain the predominant first-line treatment among these patients.
Despite the recent approval of several nmCRPC treatments that have demonstrated improved metastasis-free survival and quality of life, first-generation antiandrogens remain the predominant first-line treatment among these patients.
Despite the recent approval of...
06/03/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Financial Impact of Switching From Abiraterone to Generic Therapeutics for Patients With Prostate Cancer in the Oncology Care Model
06/03/2022

Amber Denham

Amber Denham
Therapeutic interchange from brand name to generic abiraterone in The US Oncology Network generated significant savings for the Oncology Care Model, according to a study presented at the 2022 ASCO Annual Meeting.
Therapeutic interchange from brand name to generic abiraterone in The US Oncology Network generated significant savings for the Oncology Care Model, according to a study presented at the 2022 ASCO Annual Meeting.
Therapeutic interchange from...
06/03/2022
Journal of Clinical Pathways
Conference Coverage
Oncologist vs Urologist Treatment Decision-Making for Metastatic Castration–Sensitive Prostate Cancer in the United States
06/03/2022

Janelle Bradley

Janelle Bradley
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the...
06/03/2022
Journal of Clinical Pathways
Conference Coverage
Praise, Challenges, and Outcomes of The Oncology Medical Home Certification Pilot
03/31/2022

Marta Rybczynski

Marta Rybczynski
A panel at the 2022 Community Oncology Conference discussed the building and implementation of the ASCO and COA Oncology Medical Home Model, touching on its quality, outcomes, and value in cancer care.
A panel at the 2022 Community Oncology Conference discussed the building and implementation of the ASCO and COA Oncology Medical Home Model, touching on its quality, outcomes, and value in cancer care.
A panel at the 2022 Community...
03/31/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Moving the Needle on Comprehensive Genomic Profiling
03/30/2022

Janelle Bradley

Janelle Bradley
In a session at the 2022 Community Oncology Conference, experts convened to discuss the current landscape of comprehensive genomic profiling in the United States.
In a session at the 2022 Community Oncology Conference, experts convened to discuss the current landscape of comprehensive genomic profiling in the United States.
In a session at the 2022...
03/30/2022
Journal of Clinical Pathways
Conference Coverage
Addressing Disparities in Cancer Health, Equity, and Outcomes
03/29/2022

Marta Rybczynski

Marta Rybczynski
A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer care.
A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer care.
A panel at the 2022 Community...
03/29/2022
Journal of Clinical Pathways
Conference Coverage
Precision Medicine and Value-Based Payment in Oncology
03/05/2022

Marta Rybczynski

Marta Rybczynski
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit convened industry experts to discuss innovations and obstacles in precision medicine and value-based payment in oncology.
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit convened industry experts to discuss innovations and obstacles in precision medicine and value-based payment in oncology.
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Making the Business Case for Comprehensive Cancer Care Services
03/05/2022

Janelle Bradley

Janelle Bradley
The President’s Panel at the ACCC 48th Annual Meeting and Cancer Center Business Summit discussed the innovative care models with demonstrable return on investment required for the delivery of high-impact comprehensive cancer care services.
The President’s Panel at the ACCC 48th Annual Meeting and Cancer Center Business Summit discussed the innovative care models with demonstrable return on investment required for the delivery of high-impact comprehensive cancer care services.
The President’s Panel at the...
03/05/2022
Journal of Clinical Pathways
Conference Coverage
Reconfiguration and Consolidation Trends and Their Impact on Oncology
03/05/2022

Janelle Bradley

Janelle Bradley
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought together consultants and leaders to discuss industry reconfiguration and consolidation trends and their impact on oncology.
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought together consultants and leaders to discuss industry reconfiguration and consolidation trends and their impact on oncology.
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways
Conference Coverage
New Tools to Improve Clinical Decision Making and Patient Support
03/05/2022

Marta Rybczynski

Marta Rybczynski
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use